Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 Concerted Action BMH4-CT98-3936Jacques J. M. van Dongen, Elizabeth Macintyre, A Parreira et al.|Leukemia|2003Cited by 3k
Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 studyMax S. Topp, Hagop M. Kantarjian, Nicola Gökbuget et al.|The Lancet Oncology|2014Cited by 1.3k
Clinical significance of minimal residual disease quantification in adult patients with standard-risk acute lymphoblastic leukemiaMonika Brüggemann, Michael Kneba, Thorsten Raff et al.|Blood|2005Cited by 537
Next-generation sequencing and real-time quantitative PCR for minimal residual disease detection in B-cell disordersMarco Ladetto, Christiane Pott, Monika Brüggemann et al.|Leukemia|2013Cited by 305
Standardized next-generation sequencing of immunoglobulin and T-cell receptor gene recombinations for MRD marker identification in acute lymphoblastic leukaemia; a EuroClonality-NGS validation studyAnton W. Langerak, Monika Brüggemann, Michaela Kotrová et al.|Leukemia|2019Cited by 260